Key Segmentation
By Technology
- Machine Learning
- Generative AI
By Offering
- Software Platforms
- AI-as-a-Service
By Application
- Drug Discovery & Pre-Clinical Development
- Pharmacovigilance & Safety Monitoring
By Deployment Mode
- Cloud
- On-Premises & Hybrid
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Artificial Intelligence (AI) in Pharmaceutical Market is expected to grow at a CAGR of 31.76% from 2026 to 2035.
The Artificial Intelligence (AI) in Pharmaceutical Market was valued at USD 3.07 Billion in 2025.
North America held the largest share of the Artificial Intelligence (AI) in Pharmaceutical Market in 2025, while Asia Pacific was the fastest-growing region.
The Machine Learning segment held approximately 38.21% share in 2025.
Venture funding and regulatory endorsement combined with adaptive-trial algorithms cutting enrollment timelines is the major growth factor.